Artificial Intelligence and Robotics for Lung Disease 2027

Discover how AI and robotics are revolutionising lung disease care – join leading experts to explore cutting-edge innovations in early diagnosis, precision treatment, and improved patient outcomes

Important:

Early bird ends 18 December!

Early bird discounts apply until 18 December. Register now for maximum savings

Overview

Explore the future of thoracic medicine at a convergence of artificial intelligence, advanced imaging and robotics.

Join us for a forward-looking conference exploring the rapidly evolving role of AI and robotic technologies in the diagnosis, assessment and treatment of lung cancer.

From AI-powered imaging and earlier detection of lung cancer to robotic bronchoscopy and precision-guided intervention, discover how technology is transforming the way we diagnose and manage patients with thoracic disease.

Course aims

This multidisciplinary course will provide an opportunity to:

Why attend

AI-Enhanced Imaging and Earlier Diagnosis

Discover how advances in AI are transforming thoracic imaging, and explore how sophisticated algorithms can facilitate earlier identification of lung cancer. Hear from leading radiologists, and AI scientists about the opportunities, challenges and practical applications of AI in clinical imaging.

Precision and Innovation in Robotic Bronchoscopy

See how the latest robotic bronchoscopy platforms are expanding the diagnostic and therapeutic potential of interventional pulmonology and thoracic surgery. Learn how advanced navigation, localisation and robotic technology can support accurate sampling of peripheral lung lesions, while enabling minimally invasive approaches to diagnosis and intervention.

From Earlier Diagnosis to Better Treatment

Examine how advances in diagnosis are influencing treatment pathways and patient care. Hear from specialists in oncology and thoracic surgery about contemporary approaches to lung cancer management, and explore how earlier detection, accurate staging and increasingly personalised treatment strategies can contribute to better outcomes and quality of life.

Multidisciplinary Collaboration

Connect with colleagues and experts from across radiology, respiratory medicine, thoracic surgery, oncology, pathology and primary care. Discuss challenging cases, share practical experience and explore how multidisciplinary collaboration can help translate technological advances into meaningful improvements in patient care.

Artificial Intelligence and Robotics for Lung Disease attendee

Brilliant conference. A really nice mix of expert sessions, engaging MDTs and uniformly excellent speakers. Great venue and organisation

Artificial Intelligence and Robotics for Lung Disease attendee

Excellent conference. Fantastic speakers. Covered a wide range of topics which were all relevant to the audience. Great to get differing viewpoints on tissue sampling options and surgical approaches

Artificial Intelligence and Robotics for Lung Disease attendee

I liked the overall topics, speakers and learnt a lot. Excellent discussions

Artificial Intelligence and Robotics for Lung Disease attendee

I thought this was really well organised. Well-paced, interesting and relevant content

Who should attend

This multidisciplinary course is designed for healthcare professionals involved in the diagnosis, treatment and management of lung cancer and thoracic disease, including:

Whether you are already using AI or robotic technologies in clinical practice or want to understand how these developments are shaping the future of thoracic medicine, this event will provide an opportunity to discuss from experts, explore emerging technologies and connect with colleagues across the multidisciplinary team.

Latest agenda

08:15

Registration and refreshments

08:50

Welcome

  • Prof Pallav Shah, Professor of Respiratory Medicine, Imperial College London and Consultant Physician, Royal Brompton Hospital
  • Dr Christopher Orton, Consultant Respiratory Physician, Royal Brompton Hospital, London

09:00

Lung Cancer Screening: Implementation and 5-year results

  • Dr Richard Lee, Consultant Respiratory Physician, Royal Marsden Hospital, London

09:15

AI solutions for pulmonary nodules

  • Dr Arjun Nair, Consultant Radiologist, University College London, London

09:30

The need for human decision making in nodule assessments

  • Dr Emily Bartlett, Consultant Radiologist, Royal Brompton Hospital, London

09:45

A global perspective on AI for thoracic oncology

  • Dr Colin Jacobs, Associate Professor in AI for Thoracic Oncology, Radboud University Medical Center, Nijmegen

10:00

Panel Discussion

10:15

The LUNA25 Challenge and interactive session

  • Mr Bogdan Obreja, PhD candidate, Radboud University Medical Center, Nijmegen, Netherlands

10:30

Break

11:00

Why robotic navigation bronchoscopy?

  • Dr Christopher Orton, Consultant Respiratory Physician, Royal Brompton Hospital, London

11:15

The value of adjunctive imaging: Cone beam CT and radial EBUS

  • Dr Rocco Trissolini, Consultant Respiratory Physician, Division of the Catholic University of the Sacred Hearth at Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome

11:30

Maximising biopsy yield: Cryobiopsy and Rapid On-Site Evaluation (ROSE)

  • Dr Juliana Guarize, Consultant Respiratory Physician, Istituto Europeo di Oncologia, Milan

11:45

Anaesthetic paradigms in robotic bronchoscopy

  • Dr Olivier Debrett, Consultant Anaesthetist, University College London, London

12:00

Panel discussion

12:15

Lunch

13:15

  • Diagnostic MDT panel discussion

13:45

What does the robot bring to the operative table?

  • Mr Simon Jordon, Consultant Thoracic Surgeon, Royal Brompton Hospital, London

14:00

Robotic surgery for small targets

  • Prof Andrea Bille, Consultant Thoracic Surgeon, Guys and St Thomas’, London

14:15

Robotic assisted endoluminal ablation for small targets

  • Prof Pallav Shah, Professor of Respiratory Medicine, Imperial College London and Consultant Physician, Royal Brompton Hospital, London

14:30

AI and Stereotactic Ablative Body Radiotherapy (SABR) for early-stage lung cancer

  • Dr Kathryn Banfill, Consultant Clinical Oncologist, The Christie, Manchester

14:45

Panel discussion

15:00

Break

15:30

Injectables and future perspectives

  • Prof Scott Oh, University of California, Los Angeles

15:45

Pathology: Living off scraps and steering the ship

  • Dr Dennis Zhang, Consultant Histopathologist, Royal Brompton Hospital, London

16:00

Therapeutic MDT panel discussion

16.30

Open forum

16:45

Feedback and close

16:50

Close of Event

  • Prof Pallav Shah, Professor of Respiratory Medicine, Imperial College London and Consultant Physician, Royal Brompton Hospital
  • Dr Christopher Orton, Consultant Respiratory Physician, Royal Brompton Hospital, London

How to book

Book here via Eventbrite
Important:

Need help with funding?

Bursaries are available. Please contact [email protected] for more information

GSTT Event Photography Oncology at the on the 25/06/2018. Photo: David Tett

Interested in sponsoring this event?

Sponsor and exhibitor opportunities are available